Development of mini-SSPedi for children 4–7 years of age receiving cancer treatments

BACKGROUND: The Symptom Screening in Pediatrics Tool (SSPedi) is valid for assessing symptoms in children aged 8–18 years receiving cancer treatments. The objective was to develop a new self-report symptom screening tool for children receiving cancer treatments who are 4–7 years of age (mini-SSPedi)...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Cancer
Asıl Yazarlar: Tomlinson, Deborah, Hyslop, Shannon, Stein, Eliana, Spiegler, Brenda, Vettese, Emily, Kuczynski, Susan, Schechter, Tal, Dupuis, L. Lee, Sung, Lillian
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325666/
https://ncbi.nlm.nih.gov/pubmed/30621617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-5210-z
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller